Results for tag: "Norovirus Drug"

The Norovirus Drug market is a subset of the larger Infectious Diseases Drugs market. Norovirus is a highly contagious virus that causes gastroenteritis, or inflammation of the stomach and intestines. It is the leading cause of foodborne illness in the United States. Treatment for Norovirus is largely supportive, with medications used to reduce symptoms such as nausea, vomiting, and diarrhea. Antiviral medications are also available, but are not widely used due to their limited effectiveness. The Norovirus Drug market is comprised of a variety of pharmaceutical companies, including those that specialize in the development of antiviral medications. These companies are focused on developing new treatments for Norovirus, as well as improving existing treatments. Additionally, there are companies that specialize in the production of vaccines and other preventive measures. Some of the companies in the Norovirus Drug market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Takeda. Show Less Read more